CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Operating Income Growth by Quarter and Year

Mateon Therapeutics Inc's Operating Income results by quarter and year




OXGN Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -0.90 -3.90 -3.35
III Quarter September -0.93 -0.80 -3.97 -3.98
II Quarter June -1.16 -2.44 -3.14 -3.60
I Quarter March -0.68 -3.54 -3.67 -3.33
FY   -2.77 -7.68 -14.68 -14.26



OXGN Operating Income third quarter 2019 Y/Y Growth Comment
Mateon Therapeutics Inc in the third quarter recorded Operating Loss of $ -0.93 millions.

According to the results reported in the third quarter, Mateon Therapeutics Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


OXGN Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's third quarter 2019 Operating Income $ -0.93 millions OXGN's Income Statement
Mateon Therapeutics Inc's third quarter 2018 Operating Income $ -0.80 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Operating Income Growth >>


OXGN Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Mateon Therapeutics Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Mateon Therapeutics Inc in the III. Quarter 2019 showed Operating Loss of $ -0.93 millions, some analyst point out, that current results show slight up side compare to the -1.16 millions in the second quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Operating Income growth. While Mateon Therapeutics Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's III. Quarter Q/Q Operating Income Comment
Even if Mateon Therapeutics Inc in the III. Quarter 2019 revealed Operating Loss of $ -0.93 millions, management point out, that current results show improvement in contrast to the -1.16 millions in the second quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Operating Income growth. While Mateon Therapeutics Inc's Operating Income growth quarter on quarter, overall rank is .


Mateon Therapeutics Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -3.67 $ -3.53 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
OXGN's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for OXGN's Competitors
Operating Income Growth for Mateon Therapeutics Inc's Suppliers
Operating Income Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2019
Lemaitre Vascular Inc  28.01 %$ 28.008 millions
Illumina, Inc.  27.80 %$ 27.801 millions
Advansource Biomaterials Corporation  27.73 %$ 27.731 millions
Biospecifics Technologies Corp  26.81 %$ 26.806 millions
Addus Homecare Corp  23.33 %$ 23.327 millions
Select Medical Holdings Corp  23.11 %$ 23.107 millions
United Therapeutics Corporation  22.59 %$ 22.594 millions
Quidel Corp  22.42 %$ 22.422 millions
Abbott Laboratories  20.40 %$ 20.402 millions
Orasure Technologies Inc  20.22 %$ 20.217 millions
Abiomed Inc  19.60 %$ 19.599 millions
Idexx Laboratories Inc  19.13 %$ 19.133 millions
Resmed Inc.  18.71 %$ 18.712 millions
Owens & Minor, Inc.  18.53 %$ 18.528 millions
Edwards Lifesciences Corporation  18.24 %$ 18.240 millions
Integrated Biopharma Inc  17.53 %$ 17.531 millions
Tivity Health, Inc.  17.51 %$ 17.515 millions
Amedisys Inc  17.40 %$ 17.404 millions
Intuitive Surgical, Inc.  16.73 %$ 16.725 millions
China Health Industries Holdings, Inc.  13.84 %$ 13.841 millions
Iqvia Holdings Inc.  12.71 %$ 12.707 millions
National Research Corporation  11.50 %$ 11.499 millions
Medpace Holdings, inc.  11.42 %$ 11.416 millions
Pacific Health Care Organization Inc  10.97 %$ 10.966 millions
West Pharmaceutical Services, Inc.  10.69 %$ 10.691 millions
Hanger, Inc.  9.29 %$ 9.288 millions
Stryker Corp  9.03 %$ 9.028 millions
U S Physical Therapy Inc  8.96 %$ 8.961 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ECIA's Profile

Stock Price

ECIA's Financials

Business Description

Fundamentals

Charts & Quotes

ECIA's News

Suppliers

ECIA's Competitors

Customers & Markets

Economic Indicators

ECIA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071